CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
67 hedge funds and large institutions have $80M invested in Cellular Biomedicine Group, Inc. in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
68% less call options, than puts
Call options by funds: $529K | Put options by funds: $1.64M
Holders
67
Holding in Top 10
–
Calls
$529K
Puts
$1.64M
Top Buyers
| 1 | +$1.74M | |
| 2 | +$1.52M | |
| 3 | +$1.37M | |
| 4 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$1.21M |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
+$1.18M |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$1.3M | |
| 3 | -$865K | |
| 4 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$711K |
| 5 |
Man Group
London,
United Kingdom
|
-$655K |
